• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中铁死亡的表观遗传学调控:鉴定新型抗癌治疗的表观遗传靶点。

Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, 13496, Republic of Korea.

Department of Biomedical Science, General Graduate School, CHA University, Seongnam, Republic of Korea.

出版信息

Cell Oncol (Dordr). 2023 Dec;46(6):1605-1623. doi: 10.1007/s13402-023-00840-7. Epub 2023 Jul 12.

DOI:10.1007/s13402-023-00840-7
PMID:37438601
Abstract

Ferroptosis is a newly recognized form of oxidative-regulated cell death resulting from iron-mediated lipid peroxidation accumulation. Radical-trapping antioxidant systems can eliminate these oxidized lipids and prevent disrupting the integrity of cell membranes. Epigenetic modifications can regulate ferroptosis by altering gene expression or cell phenotype without permanent sequence changes. These mechanisms include DNA methylation, histone modifications, RNA modifications, and noncoding RNAs. Epigenetic alterations in cancer can control the expression of ferroptosis regulators or related pathways, leading to changes in cell sensitivity to ferroptosis inducers or cancer progression. Epigenetic alterations in cancer are influenced by a wide range of cancer hallmarks, contributing to therapeutic resistance. Targeting epigenetic alterations is a promising approach to overcoming cancer resilience. However, the exact mechanisms involved in different types of cancer remain unresolved. Discovering more ferroptosis-associated epigenetic targets and interventions can help overcome current barriers in anticancer therapy. Many papers on epigenetic modifications of ferroptosis have been continuously published, making it essential to summarize the current state-of-the-art in the epigenetic regulation of ferroptosis in human cancer.

摘要

铁死亡是一种新发现的受氧化调控的细胞死亡形式,其发生与铁介导的脂质过氧化积累有关。自由基捕获抗氧化系统可以消除这些氧化脂质,防止破坏细胞膜的完整性。表观遗传修饰可以通过改变基因表达或细胞表型而不引起永久序列改变来调节铁死亡。这些机制包括 DNA 甲基化、组蛋白修饰、RNA 修饰和非编码 RNA。癌症中的表观遗传改变可以控制铁死亡调节剂或相关途径的表达,导致细胞对铁死亡诱导剂的敏感性或癌症进展发生变化。癌症中的表观遗传改变受到多种癌症特征的影响,导致治疗耐药性。针对表观遗传改变是克服癌症耐药性的一种有前途的方法。然而,不同类型癌症中涉及的确切机制仍未解决。发现更多与铁死亡相关的表观遗传靶标和干预措施,有助于克服当前癌症治疗中的障碍。关于铁死亡的表观遗传修饰的论文不断发表,因此有必要总结人类癌症中铁死亡的表观遗传调控的最新进展。

相似文献

1
Epigenetic modulation of ferroptosis in cancer: Identifying epigenetic targets for novel anticancer therapy.癌症中铁死亡的表观遗传学调控:鉴定新型抗癌治疗的表观遗传靶点。
Cell Oncol (Dordr). 2023 Dec;46(6):1605-1623. doi: 10.1007/s13402-023-00840-7. Epub 2023 Jul 12.
2
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.针对调节铁死亡的表观遗传和翻译后修饰以治疗疾病。
Signal Transduct Target Ther. 2023 Dec 10;8(1):449. doi: 10.1038/s41392-023-01720-0.
3
Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.靶向人类癌症中的谷胱甘肽过氧化物酶4:诱导铁死亡对应对癌症抗逆性的意义。
Cancer Lett. 2023 Apr 10;559:216119. doi: 10.1016/j.canlet.2023.216119. Epub 2023 Mar 8.
4
Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer.针对 Nrf2 的铁死亡治疗策略:克服癌症中铁死亡逃避和治疗抵抗的意义。
Biochim Biophys Acta Mol Basis Dis. 2023 Oct;1869(7):166788. doi: 10.1016/j.bbadis.2023.166788. Epub 2023 Jun 10.
5
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.非编码 RNA 对癌症耐药性中铁死亡的表观遗传修饰。
Mol Cancer. 2024 Aug 27;23(1):177. doi: 10.1186/s12943-024-02088-7.
6
Ferroptosis regulation by methylation in cancer.癌症中甲基化对铁死亡的调控
Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188972. doi: 10.1016/j.bbcan.2023.188972. Epub 2023 Aug 26.
7
The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases.铁死亡的表观遗传调控机制及其对生物学过程和疾病的影响。
MedComm (2020). 2023 May 22;4(3):e267. doi: 10.1002/mco2.267. eCollection 2023 Jun.
8
Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor.铁死亡的表观遗传调控和非表观遗传机制推动了肿瘤新兴纳米治疗学的发展。
Oxid Med Cell Longev. 2021 Jan 29;2021:8854790. doi: 10.1155/2021/8854790. eCollection 2021.
9
Epigenetic Regulation of Ferroptosis-Associated Genes and Its Implication in Cancer Therapy.铁死亡相关基因的表观遗传调控及其在癌症治疗中的意义
Front Oncol. 2022 Jan 31;12:771870. doi: 10.3389/fonc.2022.771870. eCollection 2022.
10
Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.非编码 RNA 与铁死亡之间的串扰:克服癌症进展的新曙光。
Cell Death Dis. 2020 Jul 24;11(7):580. doi: 10.1038/s41419-020-02772-8.

引用本文的文献

1
Research progress on NAT10-mediated acetylation in normal development and disease.NAT10介导的乙酰化在正常发育和疾病中的研究进展
Front Cell Dev Biol. 2025 Aug 13;13:1623276. doi: 10.3389/fcell.2025.1623276. eCollection 2025.
2
The Multifaceted Role of VIRMA, a Core Component of the Methyltransferase Complex, in Cancer and Cancer Therapy.VIRMA(甲基转移酶复合物的核心成分)在癌症及癌症治疗中的多方面作用
Biomolecules. 2025 Jun 22;15(7):912. doi: 10.3390/biom15070912.
3
Epigenetic Changes Induced by Carcinogenic Agents or Occupational Exposure with Sufficient Evidence for Bladder Cancer.

本文引用的文献

1
The roles of sirtuins in ferroptosis.沉默调节蛋白在铁死亡中的作用。
Front Physiol. 2023 Apr 20;14:1131201. doi: 10.3389/fphys.2023.1131201. eCollection 2023.
2
Long noncoding RNAs induced control of ferroptosis: Implications in cancer progression and treatment.长非编码 RNA 诱导的铁死亡调控:在癌症进展和治疗中的意义。
J Cell Physiol. 2023 May;238(5):880-895. doi: 10.1002/jcp.30992. Epub 2023 Mar 16.
3
Relationship between miRNA and ferroptosis in tumors.肿瘤中微小RNA与铁死亡之间的关系。
致癌剂或职业暴露诱导的表观遗传变化与膀胱癌有充分证据。
Cancer Prev Res (Phila). 2025 Aug 1;18(8):439-451. doi: 10.1158/1940-6207.CAPR-24-0450.
4
Deciphering Epigenetic and Post-Translational Modifications in Ferroptosis: A Scientometric and Visualization Study.解析铁死亡中的表观遗传和翻译后修饰:一项科学计量学与可视化研究
Int J Med Sci. 2025 Jan 1;22(3):508-527. doi: 10.7150/ijms.104222. eCollection 2025.
5
Inhibition of FSP1: A new strategy for the treatment of tumors (Review).抑制 FSP1:一种治疗肿瘤的新策略(综述)。
Oncol Rep. 2024 Aug;52(2). doi: 10.3892/or.2024.8764. Epub 2024 Jun 28.
6
EZH2 suppresses ferroptosis in hepatocellular carcinoma and reduces sorafenib sensitivity through epigenetic regulation of TFR2.EZH2 通过对 TFR2 的表观遗传调控抑制肝癌中的铁死亡,并降低索拉非尼敏感性。
Cancer Sci. 2024 Jul;115(7):2220-2234. doi: 10.1111/cas.16186. Epub 2024 Apr 16.
7
Ferroptosis: An Emerging Target for Bladder Cancer Therapy.铁死亡:膀胱癌治疗的新靶点
Curr Issues Mol Biol. 2023 Oct 10;45(10):8201-8214. doi: 10.3390/cimb45100517.
Front Pharmacol. 2022 Nov 4;13:977062. doi: 10.3389/fphar.2022.977062. eCollection 2022.
4
JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis.JUND/linc00976 促进胆管癌的进展和转移,通过调节 miR-3202/GPX4 轴抑制铁死亡。
Cell Death Dis. 2022 Nov 18;13(11):967. doi: 10.1038/s41419-022-05412-5.
5
m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis.m6A去甲基化酶FTO通过促进OTUB1介导的抗铁死亡作用赋予鼻咽癌放射抗性。
Transl Oncol. 2023 Jan;27:101576. doi: 10.1016/j.tranon.2022.101576. Epub 2022 Nov 4.
6
CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis.环状 RNA LRFN5 通过 PRRX2/GCH1 介导的铁死亡抑制胶质母细胞瘤的进展。
J Exp Clin Cancer Res. 2022 Oct 20;41(1):307. doi: 10.1186/s13046-022-02518-8.
7
lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.lncRNA BBOX1-AS1 沉默通过 miR-513a-3p/SLC7A11 轴促进铁死亡抑制食管鳞癌细胞进展。
Eur J Pharmacol. 2022 Nov 5;934:175317. doi: 10.1016/j.ejphar.2022.175317. Epub 2022 Oct 7.
8
CircRAPGEF5 interacts with RBFOX2 to confer ferroptosis resistance by modulating alternative splicing of TFRC in endometrial cancer.环状RAPGEF5与RBFOX2相互作用,通过调节子宫内膜癌中TFRC的可变剪接赋予铁死亡抗性。
Redox Biol. 2022 Nov;57:102493. doi: 10.1016/j.redox.2022.102493. Epub 2022 Sep 26.
9
TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis.TUG1/MAZ/FTH1 轴通过抑制铁死亡来减弱二氢青蒿素的抗胶质瘤作用。
Oxid Med Cell Longev. 2022 Sep 17;2022:7843863. doi: 10.1155/2022/7843863. eCollection 2022.
10
Novel epigenetic therapeutic strategies and targets in cancer.癌症中的新型表观遗传治疗策略与靶点
Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166552. doi: 10.1016/j.bbadis.2022.166552. Epub 2022 Sep 17.